These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19799975)

  • 1. Oxybutynin permeation in skin: the influence of drug and solvent activity.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2010 Jan; 384(1-2):67-72. PubMed ID: 19799975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of drug concentration on solvent activity in silicone membranes.
    Santos P; Machado M; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2009 Jul; 377(1-2):70-5. PubMed ID: 19439167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of penetration enhancer on drug permeation from volatile formulations.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational development of topical climbazole formulations.
    Paz-Alvarez M; Fung Tang C; Pudney PD; Lane ME
    Int J Pharm; 2024 Mar; 653():123886. PubMed ID: 38331330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent.
    Wang MY; Yang YY; Heng PW
    Int J Pharm; 2005 Feb; 290(1-2):25-36. PubMed ID: 15664127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of skin hydration and its barrier function by vehicle and permeation enhancers: a study using TGA, FTIR, TEWL and drug permeation as markers.
    Shah DK; Khandavilli S; Panchagnula R
    Methods Find Exp Clin Pharmacol; 2008 Sep; 30(7):499-512. PubMed ID: 18985178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin permeation enhancement potential of Aloe Vera and a proposed mechanism of action based upon size exclusion and pull effect.
    Cole L; Heard C
    Int J Pharm; 2007 Mar; 333(1-2):10-6. PubMed ID: 17088033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin.
    Nicoli S; Penna E; Padula C; Colombo P; Santi P
    Int J Pharm; 2006 Nov; 325(1-2):2-7. PubMed ID: 16860952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of binary and ternary solvent systems for dermal delivery of methadone.
    Kung CP; Zhang Y; Sil BC; Hadgraft J; Lane ME; Patel B; McCulloch R
    Int J Pharm; 2020 Aug; 586():119538. PubMed ID: 32540347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride.
    Trottet L; Merly C; Mirza M; Hadgraft J; Davis AF
    Int J Pharm; 2004 Apr; 274(1-2):213-9. PubMed ID: 15072797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced permeation of fentanyl from supersaturated solutions in a model membrane.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Apr; 407(1-2):72-7. PubMed ID: 21256946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
    Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
    J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
    Watkinson RM; Guy RH; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chemical enhancers on the in vitro percutaneous absorption of sumatriptan succinate.
    Femenía-Font A; Balaguer-Fernández C; Merino V; Rodilla V; López-Castellano A
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):50-5. PubMed ID: 15925502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation issues associated with transdermal fentanyl delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
    Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
    Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
    Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
    Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical delivery of climbazole to mammalian skin.
    Paz-Alvarez M; Pudney PDA; Hadgraft J; Lane ME
    Int J Pharm; 2018 Oct; 549(1-2):317-324. PubMed ID: 30055301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
    Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
    Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
    Leichtnam ML; Rolland H; Wüthrich P; Guy RH
    J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.